Abstract:Disturbed remodeling of the extracellular matrix (ECM) is frequently observed in several high-prevalence pathologies that include fibrotic diseases of organs such as the heart, lung, periodontium, liver, and the stiffening of the ECM surrounding invasive cancers. In many of these lesions, matrix remodeling mediated by fibroblasts is dysregulated, in part by alterations to the regulatory and effector systems that synthesize and degrade collagen, and by alterations to the functions of the integrin-based adhesions that normally mediate mechanical remodeling of collagen fibrils. Cell-matrix adhesions containing collagen-binding integrins are enriched with regulatory and effector systems that initiate localized remodeling of pericellular collagen fibrils to maintain ECM homeostasis. A large cadre of regulatory molecules is enriched in cell-matrix adhesions that affect ECM remodeling through synthesis, degradation, and contraction of collagen fibrils. One of these regulatory molecules is Transient Receptor Potential Vanilloid-type 4 (TRPV4), a mechanically sensitive, Ca2+-permeable plasma membrane channel that regulates collagen remodeling. The gating of Ca2+ across the plasma membrane by TRPV4 and the consequent generation of intracellular Ca2+ signals affect several processes that determine the structural and mechanical properties of collagen-rich ECM. These processes include the synthesis of new collagen fibrils, tractional remodeling by contractile forces, and collagenolysis. While the specific mechanisms by which TRPV4 contributes to matrix remodeling are not well-defined, it is known that TRPV4 is activated by mechanical forces transmitted through collagen adhesion receptors. Here, we consider how TRPV4 expression and function contribute to physiological and pathological collagen remodeling and are associated with collagen adhesions. Over the long-term, an improved understanding of how TRPV4 regulates collagen remodeling could pave the way for new approaches to manage fibrotic lesions.

Transient Receptor Potential Vanilloid Subtype 1: A Potential Therapeutic Target for Fibrotic Diseases

A TRPV4 Channel C-terminal Folding Recognition Domain Critical for Trafficking and Function.

Transient receptor potential in tissue fibrosis

Novel Insights into TRPM7 Function in Fibrotic Diseases: a Potential Therapeutic Target.

Function and therapeutic potential of transient receptor potential ankyrin 1 in fibrosis

Transient Receptor Potential Vanilloid-1 (TRPV1) Alleviates Hepatic Fibrosis via TGF-β Signaling

Focus on TRPV4 and Collagen

Transient Receptor Potential (TRP) Channels and Cardiac Fibrosis

The Role of Transient Receptor Potential Vanilloid 1 in Common Diseases of the Digestive Tract and the Cardiovascular and Respiratory System

The Vanilloid Receptor TRPV1: Role in Cardiovascular and Gastrointestinal Protection.

Role of TRPM7 in cardiac fibrosis: A potential therapeutic target (Review)

Inhibition of the transient receptor potential vanilloid 3 channel attenuates carbon tetrachloride-induced hepatic fibrosis

TRPA1: A promising target for pulmonary fibrosis?

The Multifaceted Functions of TRPV4 and Calcium Oscillations in Tissue Repair

TRPV4 regulates β1 integrin-mediated cell-matrix adhesions and collagen remodeling

The Pathophysiology Role of TRPV1 on Gastrointestinal Disease

Transient Receptor Potential Vanilloid 4: a Double-Edged Sword in the Central Nervous System

[Research Progress in the Relationship Between TRPV1 and Visceral Hypersensitivity in Functional Gastrointestinal Diseases].

The TRPA1 channel in the cardiovascular system: promising features and challenges

A mechanism for the treatment of cardiovascular and renal disease

Role of TRPV4 channel in vasodilation and neovascularization